Ian Faragher
Overview
Explore the profile of Ian Faragher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hayes I, Milanzi E, Gibbs P, Faragher I, Reece J
J Surg Oncol
. 2022 Apr;
126(3):523-534.
PMID: 35481710
Background And Objectives: Increasing lymph node harvest for right-sided colon cancer is associated with improved overall survival (OS), but most relevant studies failed to report the extent of resection. We...
12.
Tang H, Besson A, Deftereos I, Mahon B, Cho J, Faragher I, et al.
ANZ J Surg
. 2022 Mar;
92(6):1461-1465.
PMID: 35302705
Background: Colorectal cancer (CRC) is commonly treated with surgery and its success is frequently defined by cure rates. Impact on other aspects of health and wellbeing are less frequently considered...
13.
Gately L, Jalali A, Semira C, Faragher I, Croxford M, Ananda S, et al.
Acta Oncol
. 2021 Jun;
60(9):1106-1113.
PMID: 34184594
Background: Multiple meta-analyses have demonstrated that routine surveillance following colorectal cancer surgery improves survival outcomes. There is limited data on how recurrence patterns and post-recurrence outcomes vary by individual tumor...
14.
Faragher I, Tham N, Hong M, Guy S, Yeung J
BMJ Open Qual
. 2021 May;
10(2).
PMID: 33941539
Background: Surgical site infections (SSIs) are morbid and costly complications after elective colorectal surgery. SSI prevention bundles have been shown to reduce SSI in colorectal surgery, but their impact on...
15.
Roberts V, Deftereos I, Mahbub B, Simons K, Faragher I, Chan S, et al.
ANZ J Surg
. 2021 Apr;
91(5):E280-E285.
PMID: 33851493
Background: Anaemia is a common manifestation of colorectal cancer (CRC). However, appropriate workup prior to surgery and the effect of anaemia on outcomes have not been well defined. This study...
16.
Croese A, Gartrell R, Hiscock R, Lee M, Gibbs P, Faragher I, et al.
Cancer Rep (Hoboken)
. 2021 Feb;
4(3):e1346.
PMID: 33554476
Background: The association between smoking, diabetes and obesity and oncological outcomes in patients with stage III colon cancer treated with surgery and adjuvant chemotherapy is unclear. Aim: To evaluate whether...
17.
Emery J, Kyriakides M, Faragher I, Ewing H, Moss A
Intern Med J
. 2021 Jan;
51(9):1457-1462.
PMID: 33462903
Background: Managing the growing demand for colonoscopies is challenging. Aims: To assess the diagnostic performance of National and Victorian colonoscopy triage guidelines and potential redistribution of triage categories. Methods: This...
18.
Loft M, Wong H, Kosmider S, Lee M, Tie J, Wong R, et al.
Intern Med J
. 2020 Sep;
51(8):1262-1268.
PMID: 32896960
Background: Neoadjuvant chemoradiation therapy is standard-of-care treatment for locally advanced rectal cancer (LARC). A pathological complete response (pCR) following chemoradiation therapy is an early indicator of treatment benefit and associated...
19.
Tie J, Cohen J, Wang Y, Christie M, Simons K, Lee M, et al.
JAMA Oncol
. 2019 Oct;
5(12):1710-1717.
PMID: 31621801
Importance: Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual disease. However, which patients remain at high risk of recurrence after completing standard adjuvant...
20.
Williams D, Mouradov D, Browne C, Palmieri M, Elliott M, Nightingale R, et al.
Mod Pathol
. 2019 Sep;
33(3):483-495.
PMID: 31471586
TP53 mutations drive colorectal cancer development, with missense mutations frequently leading to accumulation of abnormal TP53 protein. TP53 alterations have been associated with poor prognosis and chemotherapy resistance, but data...